Since it first hit the market in 2011, millions of Americans have been prescribed Xarelto, a newer generation of blood-thinning drugs touted as an alternative to warfarin (Coumadin). But recently, healthcare experts have been questioning whether the clinical trial that led to the FDA approval... Read More

The process for determining which cases from the Xarelto multidistrict litigation in the Eastern District of Louisiana will be included in a bellwether discovery pool has been determined. U.S. District Judge Eldon Fallon issued a case management order on Nov. 20 outlining the selection criteria.... Read More

Adding to the growing list of lawsuits in the Xarelto federal multidistrict litigation (MDL), a group of four plaintiffs have come together to file a joint complaint alleging that they each suffered serious harm after using Jannsen's anticoagulant drug. The highly detailed complaint outlines the... Read More

Beginning shortly after its introduction in 2011, a number of plaintiffs have come forward alleging severe – and sometimes deadly – side effects with the anti-coagulant drug Xarelto. The drug, which was introduced to the market as a more convenient alternative to the traditional warfarin,... Read More

Thirteen plaintiffs have filed a joint Xarelto internal bleeding lawsuit over injuries allegedly sustained in connection to the popular new blood thinner. Injuries include severe gastrointestinal bleeding and brain hemorrhage, and ultimately resulted in the death of three plaintiffs (represented by their next of kin).... Read More

A recent analysis published in JAMA Internal Medicine shows that 10 percent of cases where a drug causes severe harm to patients are not reported to the FDA within the specified 15-day time period. This lag time in reporting serious adverse events endangers lives needlessly,... Read More

There is now documented evidence that Xarelto (rivaroxaban), the controversial anticoagulant used to reduce blood clots in patients with atrial fibrillation, transfers rapidly back and forth across the placenta between mother and fetus when ingested during pregnancy. A research team with The Motherisk Program at... Read More

A widow from Missouri has filed a Xarelto lawsuit against Johnson & Johnson, Janssen Research & Development, Bayer Healthcare Pharmaceuticals, et al. to demand that the defendants be held liable for the death of her husband. Dixie A. Smith, surviving spouse of Jay Christopher Smith,... Read More